Answer
Recarbrio moderately influences driving and machine use, so caution is advised because seizures, confusional states and myoclonic activity have been reported with its imipenem/cilastatin components, especially when recommended imipenem doses were exceeded.
Sources for this answer
- Recarbrio 500 mg/500 mg/250 mg powder for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 4Document updated
Sources checked